<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6658828</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31491814</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6658828</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(19)30282-7</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2019.101932</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">101932</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical variables for all groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Demographic and clinical variables for all groups.</p></caption><alt-text id="al0015">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th/><th>Controls (<italic>n</italic> = 22)</th><th>PD (<italic>n</italic> = 18)</th><th>SSD-PD (n = 18)</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td>Age</td><td>63 ± 9</td><td>64 ± 8</td><td>66 ± 7</td><td/></tr><tr><td>Gender (male %)</td><td>59</td><td>83</td><td>61</td><td/></tr><tr><td>Education (years)</td><td>11 ± 3</td><td>10 ± 5</td><td>9 ± 4</td><td/></tr><tr><td>Disease duration (years)</td><td>n.a.</td><td>3.8 ± 2.0</td><td>3.7 ± 2.4</td><td/></tr><tr><td>L-dopa equivalent dose</td><td>n.a.</td><td>274 ± 107</td><td>241 ± 109</td><td/></tr><tr><td>MMSE</td><td>28.1 ± 1.1</td><td>28.6 ± 2.0</td><td>28.0 ± 2.3</td><td/></tr><tr><td>FAB</td><td>n.a.</td><td>16 ± 2</td><td>16 ± 2</td><td/></tr><tr><td>UPDRS-III</td><td>n.a.</td><td>14 ± 5</td><td>16 ± 7</td><td/></tr><tr><td>H-Y</td><td>n.a.</td><td>1.5 ± 0.5</td><td>1.6 ± 0.4</td><td/></tr><tr><td>NPI-TOTAL SCORE<xref rid="tf0005" ref-type="table-fn">a</xref></td><td>n.a.</td><td>1.7 ± 1.4</td><td>5.4 ± 3.2</td><td>0.001<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td>SQ-anxiety</td><td>4.5 ± 3.6</td><td>5.9 ± 3.3</td><td>6.1 ± 4.4</td><td/></tr><tr><td>SQ-depression</td><td>2.9 ± 2.2</td><td>2.4 ± 2.5</td><td>4.8 ± 3.7</td><td/></tr><tr><td>SQ-somatic</td><td>4.8 ± 2.7</td><td>5.3 ± 1.9</td><td>13.3 ± 2.0</td><td>0.0001<xref rid="tf0005" ref-type="table-fn">a</xref>, <xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td>SQ-anger, hostility</td><td>3.5 ± 3.2</td><td>5.5 ± 4.7</td><td>4.4 ± 2.6</td><td/></tr><tr><td>SQ-relaxation</td><td>0.5 ± 1.0</td><td>0.5 ± 0.7</td><td>1.4 ± 1.2</td><td/></tr><tr><td>SQ-contentment</td><td>0.5 ± 0.5</td><td>0.6 ± 1.1</td><td>2.0 ± 2.0</td><td/></tr><tr><td>SQ-physical wellbeing</td><td>1.9 ± 0.9</td><td>2.5 ± 0.8</td><td>4.3 ± 1.4</td><td>0.005<xref rid="tf0005" ref-type="table-fn">a</xref> 0.01<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr><tr><td>SQ-friendliness</td><td>0.4 ± 0.7</td><td>0.8 ± 1.0</td><td>0.8 ± 0.6</td><td/></tr><tr><td>DCPR</td><td>n.a.</td><td>2.5 ± 1.4</td><td>4.0 ± 1.8</td><td>0.04<xref rid="tf0010" ref-type="table-fn">b</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: DCPR, Diagnostic Criteria for Psychosomatic Research; FAB, Frontal Assessment Battery; H—Y, Hoehn and Yahr scale; MMSE, Mini Mental State Examination; NPI, Neuropsychiatry Inventory; PD, Parkinson's disease; SSD-PD, PD patients with somatic symptoms; SQ, Symptoms Questionnaire; UPDRS-III, Unified Parkinson's Disease Rating Scale III.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005"><italic>p</italic> value from the post-hoc comparison between control group and PD.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0010"><label>b</label><p id="np0010"><italic>p</italic> value from the post-hoc comparison between PD and SSD-PD.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical variables for all groups.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>Controls (n = 22)</th><th>PD (n = 18)</th><th>SSD-PD (n = 18)</th><th>p value</th></tr></thead><tbody><tr><td>Age</td><td>63 ± 9</td><td>64 ± 8</td><td>66 ± 7</td><td/></tr><tr><td>Gender (male %)</td><td>59</td><td>83</td><td>61</td><td/></tr><tr><td>Education (years)</td><td>11 ± 3</td><td>10 ± 5</td><td>9 ± 4</td><td/></tr><tr><td>Disease duration (years)</td><td>n.a.</td><td>3.8 ± 2.0</td><td>3.7 ± 2.4</td><td/></tr><tr><td>L-dopa equivalent dose</td><td>n.a.</td><td>274 ± 107</td><td>241 ± 109</td><td/></tr><tr><td>MMSE</td><td>28.1 ± 1.1</td><td>28.6 ± 2.0</td><td>28.0 ± 2.3</td><td/></tr><tr><td>FAB</td><td>n.a.</td><td>16 ± 2</td><td>16 ± 2</td><td/></tr><tr><td>UPDRS-III</td><td>n.a.</td><td>14 ± 5</td><td>16 ± 7</td><td/></tr><tr><td>H-Y</td><td>n.a.</td><td>1.5 ± 0.5</td><td>1.6 ± 0.4</td><td/></tr><tr><td>NPI-TOTAL SCORE???</td><td>n.a.</td><td>1.7 ± 1.4</td><td>5.4 ± 3.2</td><td>0.001???</td></tr><tr><td>SQ-anxiety</td><td>4.5 ± 3.6</td><td>5.9 ± 3.3</td><td>6.1 ± 4.4</td><td/></tr><tr><td>SQ-depression</td><td>2.9 ± 2.2</td><td>2.4 ± 2.5</td><td>4.8 ± 3.7</td><td/></tr><tr><td>SQ-somatic</td><td>4.8 ± 2.7</td><td>5.3 ± 1.9</td><td>13.3 ± 2.0</td><td>0.0001???, ???</td></tr><tr><td>SQ-anger, hostility</td><td>3.5 ± 3.2</td><td>5.5 ± 4.7</td><td>4.4 ± 2.6</td><td/></tr><tr><td>SQ-relaxation</td><td>0.5 ± 1.0</td><td>0.5 ± 0.7</td><td>1.4 ± 1.2</td><td/></tr><tr><td>SQ-contentment</td><td>0.5 ± 0.5</td><td>0.6 ± 1.1</td><td>2.0 ± 2.0</td><td/></tr><tr><td>SQ-physical wellbeing</td><td>1.9 ± 0.9</td><td>2.5 ± 0.8</td><td>4.3 ± 1.4</td><td>0.005??? 0.01???</td></tr><tr><td>SQ-friendliness</td><td>0.4 ± 0.7</td><td>0.8 ± 1.0</td><td>0.8 ± 0.6</td><td/></tr><tr><td>DCPR</td><td>n.a.</td><td>2.5 ± 1.4</td><td>4.0 ± 1.8</td><td>0.04???</td></tr></tbody></table></div>Abbreviations: DCPR, Diagnostic Criteria for Psychosomatic Research; FAB, Frontal Assessment Battery; H—Y, Hoehn and Yahr scale; MMSE, Mini Mental State Examination; NPI, Neuropsychiatry Inventory; PD, Parkinson's disease; SSD-PD, PD patients with somatic symptoms; SQ, Symptoms Questionnaire; UPDRS-III, Unified Parkinson's Disease Rating Scale III.ap value from the post-hoc comparison between control group and PD.bp value from the post-hoc comparison between PD and SSD-PD.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>SQ-somatic symptoms subscale items for all groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0010"><label>Table 2</label><caption><p>SQ-somatic symptoms subscale items for all groups.</p></caption><alt-text id="al0020">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>SQ-somatic symptoms</th><th>Controls (%)</th><th>PD (%)</th><th>SSD-PD (%)</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td>Feeling healthy</td><td>100</td><td>90</td><td>58</td><td>0.02<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Feeling of not enough air</td><td>18</td><td>10</td><td>50</td><td/></tr><tr><td>Feeling fit</td><td>100</td><td>100</td><td>50</td><td>0.007<xref rid="tf0020" ref-type="table-fn">b</xref>; 0.004<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Heavy arms or legs</td><td>36</td><td>30</td><td>83</td><td/></tr><tr><td>No pain anywhere</td><td>36</td><td>40</td><td>6</td><td/></tr><tr><td>Arms and legs feel strong</td><td>73</td><td>80</td><td>50</td><td/></tr><tr><td>Appetite poor</td><td>9</td><td>0</td><td>33</td><td/></tr><tr><td>Tight head or neck</td><td>27</td><td>30</td><td>83</td><td>0.05<xref rid="tf0020" ref-type="table-fn">b</xref>; 0.02<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Choking feeling</td><td>18</td><td>10</td><td>25</td><td/></tr><tr><td>Feeling of pressure in head or body</td><td>9</td><td>10</td><td>75</td><td>0.005<xref rid="tf0020" ref-type="table-fn">b</xref>; 0.002<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Weak arms or legs</td><td>9</td><td>30</td><td>100</td><td>0.007<xref rid="tf0020" ref-type="table-fn">b</xref>; 0.0001<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>No aches anywhere</td><td>73</td><td>70</td><td>20</td><td/></tr><tr><td>Breathing difficult</td><td>27</td><td>10</td><td>33</td><td/></tr><tr><td>Parts of the body feel numb or tingling</td><td>45</td><td>70</td><td>92</td><td>0.01<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Heart beating fast or pounding</td><td>18</td><td>0</td><td>33</td><td/></tr><tr><td>Pressure on head</td><td>9</td><td>0</td><td>67</td><td>0.02<xref rid="tf0020" ref-type="table-fn">b</xref>; 0.05<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Nauseated, sick to stomach</td><td>9</td><td>20</td><td>50</td><td/></tr><tr><td>Upset bowels or stomach</td><td>27</td><td>20</td><td>67</td><td/></tr><tr><td>Muscle pains</td><td>27</td><td>50</td><td>92</td><td>0.005<xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>No unpleasant feelings in head or body</td><td>73</td><td>10</td><td>0</td><td>0.0001<xref rid="tf0015" ref-type="table-fn">a</xref>, <xref rid="tf0025" ref-type="table-fn">c</xref></td></tr><tr><td>Headaches</td><td>27</td><td>30</td><td>67</td><td/></tr><tr><td>Cramps</td><td>36</td><td>50</td><td>75</td><td/></tr><tr><td>Head pains</td><td>27</td><td>10</td><td>50</td><td/></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: SQ, Somatic symptoms; PD, Parkinson's disease; SSD-PD, PD patients with somatic symptoms.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0015"><label>a</label><p id="np0015"><italic>p</italic> value from the Kruskal-Wallis comparison between control group and PD.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0020"><label>b</label><p id="np0020"><italic>p</italic> value from the Kruskal-Wallis comparison between PD and SSD-PD.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0025"><label>c</label><p id="np0025"><italic>p</italic> value from the Kruskal-Wallis comparison between control group and SSD-PD.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">SQ-somatic symptoms subscale items for all groups.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>SQ-somatic symptoms</th><th>Controls (%)</th><th>PD (%)</th><th>SSD-PD (%)</th><th>p value</th></tr></thead><tbody><tr><td>Feeling healthy</td><td>100</td><td>90</td><td>58</td><td>0.02???</td></tr><tr><td>Feeling of not enough air</td><td>18</td><td>10</td><td>50</td><td/></tr><tr><td>Feeling fit</td><td>100</td><td>100</td><td>50</td><td>0.007???; 0.004???</td></tr><tr><td>Heavy arms or legs</td><td>36</td><td>30</td><td>83</td><td/></tr><tr><td>No pain anywhere</td><td>36</td><td>40</td><td>6</td><td/></tr><tr><td>Arms and legs feel strong</td><td>73</td><td>80</td><td>50</td><td/></tr><tr><td>Appetite poor</td><td>9</td><td>0</td><td>33</td><td/></tr><tr><td>Tight head or neck</td><td>27</td><td>30</td><td>83</td><td>0.05???; 0.02???</td></tr><tr><td>Choking feeling</td><td>18</td><td>10</td><td>25</td><td/></tr><tr><td>Feeling of pressure in head or body</td><td>9</td><td>10</td><td>75</td><td>0.005???; 0.002???</td></tr><tr><td>Weak arms or legs</td><td>9</td><td>30</td><td>100</td><td>0.007???; 0.0001???</td></tr><tr><td>No aches anywhere</td><td>73</td><td>70</td><td>20</td><td/></tr><tr><td>Breathing difficult</td><td>27</td><td>10</td><td>33</td><td/></tr><tr><td>Parts of the body feel numb or tingling</td><td>45</td><td>70</td><td>92</td><td>0.01???</td></tr><tr><td>Heart beating fast or pounding</td><td>18</td><td>0</td><td>33</td><td/></tr><tr><td>Pressure on head</td><td>9</td><td>0</td><td>67</td><td>0.02???; 0.05???</td></tr><tr><td>Nauseated, sick to stomach</td><td>9</td><td>20</td><td>50</td><td/></tr><tr><td>Upset bowels or stomach</td><td>27</td><td>20</td><td>67</td><td/></tr><tr><td>Muscle pains</td><td>27</td><td>50</td><td>92</td><td>0.005???</td></tr><tr><td>No unpleasant feelings in head or body</td><td>73</td><td>10</td><td>0</td><td>0.0001???, ???</td></tr><tr><td>Headaches</td><td>27</td><td>30</td><td>67</td><td/></tr><tr><td>Cramps</td><td>36</td><td>50</td><td>75</td><td/></tr><tr><td>Head pains</td><td>27</td><td>10</td><td>50</td><td/></tr></tbody></table></div>Abbreviations: SQ, Somatic symptoms; PD, Parkinson's disease; SSD-PD, PD patients with somatic symptoms.ap value from the Kruskal-Wallis comparison between control group and PD.bp value from the Kruskal-Wallis comparison between PD and SSD-PD.cp value from the Kruskal-Wallis comparison between control group and SSD-PD.</transformed-table></extracted-table><extracted-table><table-id>t0015</table-id><table-label>Table 3</table-label><table-caption>Significant statistical results on the comparison of the FC values among groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0015"><label>Table 3</label><caption><p>Significant statistical results on the comparison of the FC values among groups.</p></caption><alt-text id="al0025">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th>FC</th><th>F</th><th><italic>p</italic> value</th><th>SSD-PD &lt; controls</th><th>SSD-PD &lt; PD</th></tr></thead><tbody><tr><td colspan="5">Between DMN areas</td></tr><tr><td>PCC-RSFS</td><td>6.8</td><td>0.002</td><td>0.006</td><td>0.007</td></tr><tr><td>PCC-LSFS</td><td>4.2</td><td>0.02</td><td>n.s.</td><td>0.02</td></tr><tr><td>RIPL-RSFS</td><td>5.2</td><td>0.008</td><td>0.04</td><td>0.01</td></tr><tr><td>LIPL-LSFS</td><td>6.6</td><td>0.003</td><td>0.004</td><td>0.01</td></tr><tr><td>RLPC-LLPC</td><td>8.0</td><td>0.001</td><td>0.001</td><td>0.03</td></tr><tr><td colspan="5">  </td></tr><tr><td colspan="5">DMN-salience</td></tr><tr><td>PCC-ACC</td><td>3.3</td><td>0.04</td><td>n.s.</td><td>0.05</td></tr><tr><td>RMFG-RAI</td><td>5.0</td><td>0.01</td><td>0.04</td><td>0.01</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significant statistical results on the comparison of the FC values among groups.</div>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>FC</th><th>F</th><th>p value</th><th>SSD-PD &lt; controls</th><th>SSD-PD &lt; PD</th></tr></thead><tbody><tr><td colspan="5">Between DMN areas</td></tr><tr><td>PCC-RSFS</td><td>6.8</td><td>0.002</td><td>0.006</td><td>0.007</td></tr><tr><td>PCC-LSFS</td><td>4.2</td><td>0.02</td><td>n.s.</td><td>0.02</td></tr><tr><td>RIPL-RSFS</td><td>5.2</td><td>0.008</td><td>0.04</td><td>0.01</td></tr><tr><td>LIPL-LSFS</td><td>6.6</td><td>0.003</td><td>0.004</td><td>0.01</td></tr><tr><td>RLPC-LLPC</td><td>8.0</td><td>0.001</td><td>0.001</td><td>0.03</td></tr><tr><td colspan="5">  </td></tr><tr><td colspan="5">DMN-salience</td></tr><tr><td>PCC-ACC</td><td>3.3</td><td>0.04</td><td>n.s.</td><td>0.05</td></tr><tr><td>RMFG-RAI</td><td>5.0</td><td>0.01</td><td>0.04</td><td>0.01</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>